Medicine

Kannan Kasturi, L. Fernandes, M. Quezado, M. Eid, L. Marcus, P. Chittiboina, M. Rappaport, C. Stratakis, B. Widemann, M. Lodish

2017.6.1Journal of Clinical and Translational Endocrinology: Case Reports

DOI: 10.1016/j.jecr.2017.02.001

tlooto-Zusammenfassung

This patient is the first individual with MEN2B to be described with Cushing disease and the RET oncogene may play a role in pituitary tumorigenesis; alternatively, the coexistence of these two entities may represent an extremely rare coincidence.

Abstract

CONTEXT Multiple endocrine neoplasia type 2B (MEN2B) is a rare autosomal-dominant cancer syndrome characterized in part by metastatic medullary thyroid cancer (MTC) and pheochromocytoma. Cushing disease is a rare cause of endogenous hypercortisolism in children.

CASE DESCRIPTION We describe a 21-year-old African-American male who was diagnosed at age 10 with an ACTH-secreting pituitary microadenoma. At age 16 he developed medullary thyroid cancer and was found to have multiple endocrine neoplasia type 2B with the characteristic M918T mutation of the RET proto-oncogene. Following thyroidectomy, he was initiated on Vandetanib, a tyrosine kinase inhibitor, and has since had stable disease over the last 5 years.

CONCLUSIONS Our patient is the first individual with MEN2B to be described with Cushing disease. The RET oncogene may play a role in pituitary tumorigenesis; alternatively, the coexistence of these two entities may represent an extremely rare coincidence.

Zitationsformat

KASTURI, Kannan, et al. Cushing disease in a patient with multiple endocrine neoplasia type 2b. Journal of Clinical and Translational Endocrinology: Case Reports, 2017, 4: 1–4.